?????/d&t/jan200

Drugs & Therapy
Committee met January 16, 2001.
5 drugs or dosage forms were added in the Formulary and 3 weredeleted. 2 drugs and 1 dosage form were reviewed and designated notavailable.
& Safety website (http://www.ehs.ufl.
Antihemophilic factor,
recombinant [formulated
must explicitly list all the prescription with sucrose]
(Helixate® FS by Baxter)
Argatroban
(Argatroban by SmithKline
Beecham)
ber and an expiration date. A copy ofthis letter must be provided to a whole- Didanosine
(Videx® EC by Bristol-Myers
Lopinavir & Ritonavir
(Kaletra® by Abbott)
Rifabutin
(Mycobutin® by Pharmacia
wholesalers that service the Gaines-ville area and a list is available from Tretinoin
(Vesanoid® by Roche)
Antihemophilic factor,
recombinant
can be contacted by calling 338-2147.
(Helixate® by Baxter)
Phenylpropanolamine
(eg, Dimetapp® by Robins)
Triple sulfa vaginal cream
not impacted by these changes. If the
(Sultrin® by Ortho)
Diazepam rectal gel
(Diastat® by Elan)
Dolasetron
(Anzemet® by Aventis)
tions. Before you can obtain prescrip-tion medications for research, teach- Granisetron
(Kytril® by SmithKline Beecham)
Bureau of Pharmacy Services of theFlorida Department of Health. The bureau’s Tallahassee telephonenumber is (850) 487-1257. Sample Formulary, from page 1
Recombinant antihemophilic
factor formulated with sucrose (thus
same product, recombinant antihe-
mophilic factor, formulated with
associated with Kaletra® is diarrhea.
has been added to the “FS” product.
after the infusion of 2 billion units.
Argatroban is a selective direct
Rifabutin is a rifamycin antibiotic
Enteric-coated didanosine is a new
The combination of lopinavir and
ritonavir is the most recently approved
inhibitor approved in the United States.
Formulary, from page 2
discoloration of tears may also
occur during rifabutin therapy. In
Only 1 antibiotic (linezolid) and 1 anti- crease from last year’s 35 approvals.
Tretinoin (also known as all-trans-
military’s approval of a paste to use with through the FDA’s review process. It was abortifacient that is used in combination with another prostaglandin, misoprostol.
2000 are also included in the table.
for the induction of remission only.
however, more are anticipated in 2001.
NEW DRUGS & SELECTED BIOLOGICS APPROVED BY FDA IN 2000 tretinoin for APL is 45 mg/m2/dayadministered as 2 evenly divided doses until remission is docu-mented. Therapy is stopped 30 Crotalide polyvalent immune fab, ovine†‡ Triple sulfa vaginal cream is a
Perfluoroalkylpolyether; Polytetrafluoroethylene Pneumococcal 7-valent conjugate vaccine‡† could result in serious allergic reac-tions in patients with a history of Drugs & Therapy
This publication is produced by theDrug Information and PharmacyResource Center under the direction ofthe Department of Pharmacy Servicesand the Pharmacy and TherapeuticsCommittee.
EDITOR,DRUGS & THERAPY BULLETINRandy C. Hatton, PharmD DIRECTOR,PHARMACY SERVICESAlan Knudsen, MS, RPh CHAIRMAN,PHARMACY & THERAPEUTICSCOMMITTEERicardo Gonzalez-Rothi, MD EDITING, DESIGN, & PRODUCTIONShands HealthCare’s Publication Svcs.
 Copyright 2001. All rights reserved.
No portion of the Drugs & TherapyBulletin may be reproduced withoutthe written consent of its editor.
Formulary, from page 3
Phenylpropanolamine is an over-
labeled dosage (ie, 32 mg IV = $64).
Dolasetron and granisetron are
Diazepam rectal gel is a prefilled
bouts of increased seizure activity.
designed for the outpatient setting.

Source: http://professionals.ufhealth.org/files/2011/11/0201-drugs-therapy-bulletin.pdf